Figure 5From: Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in VivoAnti-tumor effects of celecoxib on DMBA induced breast cancer. A. the incidence rate of the different groups; B. the tumor latency period of the different groups; C. the average tumor volumes of the different groups. Values represent means ± standard deviations and were determined using the Student’s t-test. *P < 0.05 vs tumor control group.Back to article page